ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 342

Presence of Vertebral Fractures and Disc Disease in Post Menopausal Females with Height Loss As a Possible Screening Method for Osteoporosis

Nicola Berman1, Gregory Chang2 and Stephen Honig1, 1Rheumatology, New York University Department of Rheumatology, New York, NY, 2Radiology, New York University Department of Radiology, New York, NY

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: fractures and osteoporosis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2016

Title: Osteoporosis and Metabolic Bone Disease – Clinical Aspects and Pathogenesis - Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: The presence of non-traumatic vertebral fracture can identify a patient who has clinical osteoporosis. However, approximately 75% of vertebral fractures are asymptomatic and as many as 45% of vertebral fractures in North America go unrecognized. As a result, a significant number of cases of osteoporosis are missed and left untreated, leaving patients vulnerable to future fractures and morbidity and contributing to the economic burden of osteoporosis related fractures in the United States. We investigated whether women with 2 or more inches of height loss have a high incidence of fractures, whether the degree of height loss correlates with presence of fractures, and how these findings correlate with bone density, in order to test whether height loss could be a potential screening tool for osteoporosis. Additionally, we assessed how many of these patients with 2 or more inches of height loss had been treated for osteoporosis in the past.

Methods: From among all postmenopausal female patients seen at our academic Osteoporosis Center, we prospectively enrolled a cohort of 100 subjects self-reporting two or more inches of height loss from maximum height. Enrollment occurred over a two-year period. Patients with a history of spinal surgery or significant scoliosis (>10% spinal curvature) were excluded. At intake, all patients had radiographs of the lumbar and thoracic spine (AP and lateral). A vertebral fracture was defined as >20% vertebral height loss based on the guidelines from the Vertebral Fracture Initiative by the International Osteoporosis Foundation. Intervertebral disc disease was classified based on the Genant modification of the Sharp method.

Results: Of 100 patients with height loss, 76 had a fracture of the thoracic or lumbar spine, or both. 58 women had fractures of their thoracic spine and 50 of their lumbar spine. Among the 76 women with a diagnosis of fracture, 21 (28%) had never been treated for osteoporosis. Among the 24 patients without fractures, the average T-Score was -2.0 of the spine. Among all the patients, 96 had intervertebral disc disease (94 had thoracic and 75 had lumbar disc disease). When evaluating the degree of height loss in all of the patients, there was no significant difference between the patients who had sustained a fracture and those who had not.

Conclusion: In this study, 2 or more inches of height loss was explained by vertebral fracture and presence of disc disease, or both, with the majority of subjects demonstrating fractures pathognomonic for osteoporosis. Individuals with 2 or more inches of height loss and no fractures had T scores mainly in the osteopenic-osteoporotic range. Our data therefore suggest that any patient with 2 or more inches of height loss should be evaluated for both vertebral fractures and osteoporosis. Significantly, 28% of women with radiographic findings of compression fracture had not previously been treated for osteoporosis, underlining the need for better screening and treatment.


Disclosure: N. Berman, None; G. Chang, None; S. Honig, None.

To cite this abstract in AMA style:

Berman N, Chang G, Honig S. Presence of Vertebral Fractures and Disc Disease in Post Menopausal Females with Height Loss As a Possible Screening Method for Osteoporosis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/presence-of-vertebral-fractures-and-disc-disease-in-post-menopausal-females-with-height-loss-as-a-possible-screening-method-for-osteoporosis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/presence-of-vertebral-fractures-and-disc-disease-in-post-menopausal-females-with-height-loss-as-a-possible-screening-method-for-osteoporosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology